President Joe Biden, the National Institutes of Health or some scientific leader. We need to gain scientists across a variety of disciplines, including those new to the influenza field.īut Gellin said such an effort needs leadership - whether it comes from U.S.
The creation of such a vaccine will require a diverse range of expertise - an all-hands-on-deck approach to see who might have some perspective on the way the viruses work or the way immunity works that's going to help us to develop and design these vaccines, he said. you're always chasing the virus.Īn effort is needed to produce a vaccine that is broadly protective against whatever virus emerges but that also has long-term protection, Gellin said, so you wouldn't have to get boosters, because this virus is going to be with us for a long time. But the point is, sooner or later, that's going to happen, he said.
We'll see what happens or if there's a need to do something else. The delta variant didn't need a delta-specific vaccine, and scientists are currently trying to determine whether the current vaccine is as effective with the omicron variant. 'All-hands-on-deck' approach neededĪnd that's what's currently happening with the coronavirus variants, Gellin said. He told CBC News that a different approach needs to be taken than the one that is used every year to battle influenza, in which the goal is to find the right formulation of the vaccine that best matches the flu viruses that are circulating.īut in doing so, you're always being reactive, he said. Department of Health and Human Services, recently told the U.S.-based online site Politico (new window) that a universal vaccine, or pancoronavirus vaccine, is probably the most important project that we can undertake. Gellin, a former director of the National Vaccine Program at the U.S. ANALYSISWhy Trump's Operation Warp Speed is credited with helping race for COVID-19 vaccine (new window).administration under then-president Donald Trump to manufacture COVID-19 vaccines as fast as possible. Operation Warp Speed was initiated by the U.S. and has enough protection over a long time, ideally lifetime. The holy grail here is the vaccine that is broadly protective. It will require the best the science has to offer, Gellin said. Bruce Gellin, a world-renowned vaccine and infectious disease expert who is now chief of global public health strategy at the New York-based Rockefeller Foundation, told CBC News. The long-term need is like other vaccines, where the vaccine is there before the problem is there, Dr.
0 kommentar(er)
